BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shoukry NH, Feld JJ, Grebely J. Hepatitis C: A Canadian perspective. CanLivJ 2018;1:1-3. [DOI: 10.3138/canlivj.1.2.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Chan J, Kim JJ, Barrett BK, Hamadeh A, Feld JJ, Wong WWL. Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. J Viral Hepat 2021;28:260-7. [PMID: 33065774 DOI: 10.1111/jvh.13419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Clementi E, Bartlett S, Otterstatter M, Buxton JA, Wong S, Yu A, Butt ZA, Wilton J, Pearce M, Jeong D, Binka M, Adu P, Alvarez M, Samji H, Abdia Y, Wong J, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team. Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services. Int J Infect Dis 2020;100:27-33. [PMID: 32810594 DOI: 10.1016/j.ijid.2020.08.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kendall CE, Fitzgerald M, Donelle J, Kwong JC, Galanakis C, Boyd R, Cooper CL. A cross-sectional study of prolonged disengagement from clinic among people with HCV receiving care in a low-threshold, multidisciplinary clinic. CanLivJ 2020;3:212-23. [DOI: 10.3138/canlivj.2019-0020] [Reference Citation Analysis]